Farah H. Bardai, Ph.D.

Affiliations: 
2012 Molecular and Cell Biology University of Texas at Dallas, Richardson, TX, United States 
 2013- Pathology Brigham & Women's Hospital/Harvard Medical School, Boston, MA, United States 
Area:
Neurodegenerative diseases, HDACs, Parkinson's Disease
Google:
"Farah Bardai"
Mean distance: 18.08 (cluster 6)
 

Parents

Sign in to add mentor
Santosh D'Mello grad student 2012 UT Dallas
 (Class I histone deacetylase proteins and neurodegeneration.)
Mel  B. Feany post-doc 2013- Harvard Medical School - Brigham and Women's Hospital
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bardai FH, Wang L, Mutreja Y, et al. (2017) A conserved cytoskeletal signaling cascade mediates neurotoxicity of FTDP-17 tau mutations in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Bardai FH, Verma P, Smith C, et al. (2013) Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11833-8
Bardai FH, Price V, Zaayman M, et al. (2012) Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death. The Journal of Biological Chemistry. 287: 35444-53
Dastidar SG, Bardai FH, Ma C, et al. (2012) Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2846-55
Bardai FH, D'Mello SR. (2011) Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 1746-51
See more...